CD8A and breast carcinoma: To further delineate ancestry-associated immune and stromal heterogeneity within molecular subtypes, we compared GSVA-derived immune, CD8+ T-cell, endothelial, and fibroblast scores across PAM50 breast cancer subtypes (Figs. 5–8).